These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2371030)

  • 1. DNA content as a prognostic factor in endometrial carcinoma.
    Newbury R; Schuerch C; Goodspeed N; Fanning J; Glidewell O; Evans M
    Obstet Gynecol; 1990 Aug; 76(2):251-7. PubMed ID: 2371030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma].
    Xue F; Jiao S; Zhao F
    Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):216-9. PubMed ID: 8758776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
    Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
    J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of DNA measurements in endometrial carcinoma.
    Moberger B; Auer G; Forsslund G; Moberger G
    Cytometry; 1984 Jul; 5(4):430-6. PubMed ID: 6468182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell cycle in patients with stage I endometrial carcinoma.
    Vecek N; Nola M; Marusić M; Babić D; Uzarević B; Sabioncello A; Petrovecki M; Ljubić-Racunica N; Marinović T
    Gynecol Oncol; 1994 Apr; 53(1):38-43. PubMed ID: 8175020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
    Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
    Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of DNA content in bladder cancer based on flow cytometric analysis of 249 transitional cell carcinomas.
    Vindeløv LL; Christensen IJ; Engelholm SA; Guldhammer BH; Højgaard K; Sørensen BL; Wolf H
    Cytometry; 1995 Jun; 22(2):93-102. PubMed ID: 7587754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
    Shimizu K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometrical DNA- and clinical parameters in the prediction of prognosis in stage I-II endometrial carcinoma.
    Lindahl B; Gullberg B
    Anticancer Res; 1991; 11(1):397-401. PubMed ID: 2018376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial carcinomas--flow cytometric DNA content and S-phase values.
    Jacobsen M; Jakobsen A; Nedergaard L; Andersen JE; Nielsen K
    Pathol Res Pract; 1997; 193(4):283-90. PubMed ID: 9258954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
    Goodman A; Bell DA; Rice LW
    Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
    Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
    Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of cell kinetics in endometrial adenocarcinoma.
    Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
    Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.